Allergan, Inc. v. Aurobindo Pharma Limited et al
| Allergan, Inc. |
| Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc. and Eugia Pharma Specialties Limited |
| 1:2021cv01808 |
| December 23, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 14, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney Katherine A. Helm for Allergan, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Minute Entry for proceedings held before Judge Richard G. Andrews - Rule 16(b) Telephone Scheduling Conference held on 2/14/2022. Counsel for Plaintiff: J. Tigan. Counsel for Defendant: E. Ormerod. The parties are directed to resubmit the proposed scheduling order with the dates given during the telephone conference. (Court Reporter Heather Triozzi.) (lak) |
| Filing 16 Letter to The Honorable Richard G. Andrews, from Sarah E. Simonetti, regarding dial-in for Rule 16 Conference. (Simonetti, Sarah) Modified on 2/11/2022 (nms). |
| Filing 15 PROPOSED Scheduling Order, by Allergan, Inc.. (Attachments: #1 Letter)(Simonetti, Sarah) Modified on 2/10/2022 (nms). |
| Pro Hac Vice Attorney Pejmon Pashai for Allergan, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Howard W. Levine, Katherine A. Helm, and Pejmon Pashai - filed by Allergan, Inc.. (Tigan, Jeremy) |
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Howard W. Levine, Katherine A. Helm, and Pejmon Pashai, filed by Allergan, Inc.. Signed by Judge Richard G. Andrews on 1/31/2022. (nms)
|
|
Filing 13
Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 2/14/2022, at 3:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 1/28/2022. (nms)
|
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Edward D. Pergament, Kenneth S. Canfield, Julia S. Kim - filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Limited. (Belgam, Neal) |
|
SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Edward D. Pergament, Kenneth S. Canfield, Julia S. Kim, filed by Eugia Pharma Specialties Limited, Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma Limited. Signed by Judge Richard G. Andrews on 1/27/2022. (nms)
|
| Pro Hac Vice Attorneys Kenneth S. Canfield, Dmitry V. Shelhoff, Edward D. Pergament, Julia S. Kim for Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., and Eugia Pharma Specialties Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Filing 11 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Limited. (Ormerod, Eve) |
| Filing 10 ANSWER to #1 Complaint, by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Limited.(Ormerod, Eve) Modified on 1/25/2022 (nms). |
| Filing 9 WAIVER OF SERVICE returned executed by Allergan, Inc.: For Eugia Pharma Specialties Limited waiver sent on 12/29/2021, answer due 2/28/2022. (Tigan, Jeremy) |
| Filing 8 WAIVER OF SERVICE returned executed by Allergan, Inc.: For Aurobindo Pharma U.S.A., Inc. waiver sent on 12/29/2021, answer due 2/28/2022. (Tigan, Jeremy) |
| Filing 7 WAIVER OF SERVICE returned executed by Allergan, Inc.: For Aurobindo Pharma Limited waiver sent on 12/29/2021, answer due 2/28/2022. (Tigan, Jeremy) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 6 Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Limited on 12/23/2021; Aurobindo Pharma U.S.A., Inc. on 12/23/2021; Eugia Pharma Specialties Limited on 12/23/2021. (apk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan, Inc. filed by Allergan, Inc. (apk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,858,961 B2. (apk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/12/2021. Date of Expiration of Patent: 09/2/2023.Thirty Month Stay Deadline: 5/12/2024. (apk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3769838.) - filed by Allergan, Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(apk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
